Oncogenic Chromatin Modifier KAT2A Activates MCT1 to Drive the Glycolytic Process and Tumor Progression in Renal Cell Carcinoma
Yuanyuan Guo(First Affiliated Hospital of Bengbu Medical College), Li Chen(Zhejiang Chinese Medical University)
Cited by 32
Related Papers
Clonality and Evolutionary History of Rhabdomyosarcoma
|PLoS Genetics|2015|76
Long Noncoding RNA H19 Derived from M2 Tumor-Associated Macrophages Promotes Bladder Cell Autophagy via Stabilizing ULK1
|Journal of Oncology|2022|28
Centromere protein U enhances the progression of bladder cancer by promoting mitochondrial ribosomal protein s28 expression
|Korean Journal of Physiology and Pharmacology|2021|13
M2 Tumor Associate Macrophage- (TAM-) Derived lncRNA HISLA Promotes EMT Potential in Bladder Cancer
|Journal of Oncology|2022|8